Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Director departure
CASI Pharmaceuticals, Inc (DE) (CASI) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/14/2022 8-K Quarterly results
08/12/2022 8-K Quarterly results
Docs: "CASI PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2022 FINANCIAL RESULTS ROCKVILLE, MD. and BEIJING, China CASI Pharmaceuticals, Inc. , a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported financial results for the second quarter of 2022. Wei-Wu He, Ph.D., CASI’ s Chairman and Chief Executive Officer, commented, “We are pleased to report $8.6 million in EVOMELA ® sales revenue for the second quarter of 2022. This is an increase of 19% compared to the same period last year. Our sales and marketing team is proven to be resilient, rapidly adapting strategies to address COVID-19 related challenges to ensure that our priories remain on track.” Dr. He continued, “Equipped with experience from EVOMELA and the ab..."
05/12/2022 8-K Quarterly results
03/28/2022 8-K Quarterly results
Docs: "CASI PHARMACEUTICALS ANNOUNCES FULL-YEAR 2021 FINANCIAL RESULTS AND FOURTH QUARTER 2021 EVOMELA ® REVENUE"
02/16/2022 8-K Quarterly results
Docs: "CASI PHARMACEUTICALS ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL-YEAR 2021 REVENUES AND PROVIDES BUSINESS UPDATES"
11/12/2021 8-K Quarterly results
Docs: "CASI PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2021 FINANCIAL RESULTS"
08/12/2021 8-K Quarterly results
Docs: "CASI PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2021 FINANCIAL RESULTS"
03/30/2021 8-K Quarterly results
02/16/2021 8-K Quarterly results
11/09/2020 8-K Quarterly results
Docs: "CASI PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2020 FINANCIAL RESULTS"
08/10/2020 8-K Quarterly results
05/11/2020 8-K Quarterly results
Docs: "CASI PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2020 FINANCIAL RESULTS"
03/16/2020 8-K Quarterly results
11/12/2019 8-K Quarterly results
08/09/2019 8-K Quarterly results
Docs: "CASI PHARMACEUTICALS ANNOUNCES SECOND QUARTER AND FIRST HALF 2019 FINANCIAL AND BUSINESS RESULTS"
05/15/2019 8-K Quarterly results
Docs: "CASI PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2019 FINANCIAL AND BUSINESS RESULTS · Acquired Exclusive Global Rights to CID-103, a Novel Anti-CD38 Monoclonal Antibody · Entered into China Distribution Agreement for EVOMELA ® · Received National Medical Products Administration Approval of Clinical Trial Applications for ZEVALIN and for MARQIBO ® · Chairman Wei-Wu He, Ph.D. Expanded Role to Include Chief Executive Officer ROCKVILLE, Md. – CASI Pharmaceuticals, Inc. , a U.S. pharmaceutical company with a platform to develop and accelerate the launch of innovative therapeutics and pharmaceutical products in China, the U.S., and throughout the world, today reported financial results for the first quarter 2019 and provided a review of recent accomplishments and anticip..."
03/29/2019 8-K Quarterly results
Docs: "CASI PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2018 FINANCIAL RESULTS AND BUSINESS RESULTS · Announced distribution partner for Melphalan Hydrochloride for Injection to support commercialization in China following NMPA approval in December of 2018 · Announced NMPA approval of CTAs to conduct confirmatory registration trials for vincristine sulfate LIPOSOME injection and Ibritumomab Tiuxetan · Announced plans to build GMP manufacturing site in Wuxi, China · Announced acquisition of ANDA for HBV from Laurus Labs · Announced key new hires to support global commercialization efforts ROCKVILLE, Md. – CASI Pharmaceuticals, Inc. , a U.S. pharmaceutical company with a platform to develop and accelerate the launch of pharmaceutical products and innova..."
11/14/2018 8-K Quarterly results
Docs: "CASI PHARMACEUTICALS ANNOUNCES THIRD QUARTER AND FIRST NINE MONTHS 2018 FINANCIAL AND BUSINESS RESULTS"
08/14/2018 8-K Quarterly results
Docs: "CASI PHARMACEUTICALS ANNOUNCES SECOND QUARTER AND FIRST HALF 2018 FINANCIAL AND BUSINESS RESULTS"
05/15/2018 8-K Quarterly results
Docs: "CASI PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2018 FINANCIAL AND BUSINESS RESULTS"
03/29/2018 8-K Quarterly results
Docs: "CASI PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS"
11/14/2017 8-K Quarterly results
Docs: "CASI PHARMACEUTICALS REPORTS THIRD QUARTER 2017 FINANCIAL RESULTS"
08/14/2017 8-K Quarterly results
Docs: "CASI PHARMACEUTICALS REPORTS SECOND QUARTER 2017 FINANCIAL RESULTS"
05/15/2017 8-K Form 8-K - Current report
03/31/2017 8-K Form 8-K - Current report
11/14/2016 8-K Quarterly results
Docs: "CASI PHARMACEUTICALS REPORTS THIRD QUARTER 2016 FINANCIAL RESULTS"
08/15/2016 8-K Quarterly results
Docs: "CASI PHARMACEUTICALS REPORTS SECOND QUARTER 2016 FINANCIAL RESULTS"
03/28/2016 8-K Quarterly results
Docs: "CASI PHARMACEUTICALS REPORTS 2015 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS"
08/14/2013 8-K Quarterly results
Docs: "ENTREMED REPORTS SECOND QUARTER 2013 FINANCIAL RESULTS"
03/21/2013 8-K Quarterly results
Docs: "ENTREMED REPORTS FOURTH QUARTER AND YEAR-END 2012 FINANCIAL RESULTS AND BUSINESS OUTLOOK FOR 2013"
11/14/2012 8-K Quarterly results
Docs: "ENTREMED REPORTS THIRD QUARTER 2012 FINANCIAL RESULTS"
08/14/2012 8-K Quarterly results
Docs: "ENTREMED REPORTS SECOND QUARTER 2012 FINANCIAL RESULTS"
05/15/2012 8-K Quarterly results
Docs: "ENTREMED REPORTS FIRST QUARTER 2012 FINANCIAL RESULTS"
03/09/2012 8-K Quarterly results
Docs: "ENTREMED REPORTS FOURTH QUARTER AND YEAR-END 2011 FINANCIAL RESULTS"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy